Point-of-Care Molecular Diagnostics Market Size, Share, and Trends 2024 to 2034

The global point-of-care molecular diagnostics market size is calculated at USD 8.95 billion in 2025 and is forecasted to reach around USD 12.61 billion by 2034, accelerating at a CAGR of 3.87% from 2025 to 2034. The North America market size surpassed USD 3.98 billion in 2024 and is expanding at a CAGR of 3.90% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 3360
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Molecular Diagnostics Market 

5.1. COVID-19 Landscape: Point-of-Care Molecular Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Molecular Diagnostics Market, By Technology

8.1. Point-of-Care Molecular Diagnostics Market, by Technology

8.1.1. PCR-based

8.1.1.1. Market Revenue and Forecast

8.1.2. Genetic Sequencing-based

8.1.2.1. Market Revenue and Forecast

8.1.3. Hybridization-based

8.1.3.1. Market Revenue and Forecast

8.1.4. Microarray-based

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Point-of-Care Molecular Diagnostics Market, By Application

9.1. Point-of-Care Molecular Diagnostics Market, by Application

9.1.1. Infectious Diseases

9.1.1.1. Market Revenue and Forecast

9.1.2. Oncology

9.1.2.1. Market Revenue and Forecast

9.1.3. Hematology

9.1.3.1. Market Revenue and Forecast

9.1.4. Prenatal Testing

9.1.4.1. Market Revenue and Forecast

9.1.5. Endocrinology

9.1.5.1. Market Revenue and Forecast

9.1.6. Other

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Point-of-Care Molecular Diagnostics Market, By Location 

10.1. Point-of-Care Molecular Diagnostics Market, by Location

10.1.1. OTC

10.1.1.1. Market Revenue and Forecast

10.1.2. POC

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Point-of-Care Molecular Diagnostics Market, By End Use 

11.1. Point-of-Care Molecular Diagnostics Market, by End Use

11.1.1. Decentralized Labs

11.1.1.1. Market Revenue and Forecast

11.1.2. Hospitals

11.1.2.1. Market Revenue and Forecast

11.1.3. Homecare

11.1.3.1. Market Revenue and Forecast

11.1.4. Assisted Living Healthcare Facilities

11.1.4.1. Market Revenue and Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Point-of-Care Molecular Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology

12.1.2. Market Revenue and Forecast, by Application

12.1.3. Market Revenue and Forecast, by Location

12.1.4. Market Revenue and Forecast, by End Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology

12.1.5.2. Market Revenue and Forecast, by Application

12.1.5.3. Market Revenue and Forecast, by Location

12.1.5.4. Market Revenue and Forecast, by End Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology

12.1.6.2. Market Revenue and Forecast, by Application

12.1.6.3. Market Revenue and Forecast, by Location

12.1.6.4. Market Revenue and Forecast, by End Use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology

12.2.2. Market Revenue and Forecast, by Application

12.2.3. Market Revenue and Forecast, by Location

12.2.4. Market Revenue and Forecast, by End Use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology

12.2.5.2. Market Revenue and Forecast, by Application

12.2.5.3. Market Revenue and Forecast, by Location

12.2.5.4. Market Revenue and Forecast, by End Use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology

12.2.6.2. Market Revenue and Forecast, by Application

12.2.6.3. Market Revenue and Forecast, by Location

12.2.6.4. Market Revenue and Forecast, by End Use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology

12.2.7.2. Market Revenue and Forecast, by Application

12.2.7.3. Market Revenue and Forecast, by Location

12.2.7.4. Market Revenue and Forecast, by End Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology

12.2.8.2. Market Revenue and Forecast, by Application

12.2.8.3. Market Revenue and Forecast, by Location

12.2.8.4. Market Revenue and Forecast, by End Use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology

12.3.2. Market Revenue and Forecast, by Application

12.3.3. Market Revenue and Forecast, by Location

12.3.4. Market Revenue and Forecast, by End Use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology

12.3.5.2. Market Revenue and Forecast, by Application

12.3.5.3. Market Revenue and Forecast, by Location

12.3.5.4. Market Revenue and Forecast, by End Use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology

12.3.6.2. Market Revenue and Forecast, by Application

12.3.6.3. Market Revenue and Forecast, by Location

12.3.6.4. Market Revenue and Forecast, by End Use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology

12.3.7.2. Market Revenue and Forecast, by Application

12.3.7.3. Market Revenue and Forecast, by Location

12.3.7.4. Market Revenue and Forecast, by End Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology

12.3.8.2. Market Revenue and Forecast, by Application

12.3.8.3. Market Revenue and Forecast, by Location

12.3.8.4. Market Revenue and Forecast, by End Use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology

12.4.2. Market Revenue and Forecast, by Application

12.4.3. Market Revenue and Forecast, by Location

12.4.4. Market Revenue and Forecast, by End Use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology

12.4.5.2. Market Revenue and Forecast, by Application

12.4.5.3. Market Revenue and Forecast, by Location

12.4.5.4. Market Revenue and Forecast, by End Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology

12.4.6.2. Market Revenue and Forecast, by Application

12.4.6.3. Market Revenue and Forecast, by Location

12.4.6.4. Market Revenue and Forecast, by End Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology

12.4.7.2. Market Revenue and Forecast, by Application

12.4.7.3. Market Revenue and Forecast, by Location

12.4.7.4. Market Revenue and Forecast, by End Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology

12.4.8.2. Market Revenue and Forecast, by Application

12.4.8.3. Market Revenue and Forecast, by Location

12.4.8.4. Market Revenue and Forecast, by End Use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology

12.5.2. Market Revenue and Forecast, by Application

12.5.3. Market Revenue and Forecast, by Location

12.5.4. Market Revenue and Forecast, by End Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology

12.5.5.2. Market Revenue and Forecast, by Application

12.5.5.3. Market Revenue and Forecast, by Location

12.5.5.4. Market Revenue and Forecast, by End Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology

12.5.6.2. Market Revenue and Forecast, by Application

12.5.6.3. Market Revenue and Forecast, by Location

12.5.6.4. Market Revenue and Forecast, by End Use

Chapter 13. Company Profiles

13.1. Abbott Laboratories, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Roche Diagnostics

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. bioMérieux SA

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Danaher Corporation (Beckman Coulter)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Cepheid (a subsidiary of Danaher Corporation)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. QIAGEN N.V.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Thermo Fisher Scientific, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Hologic, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Bio-Rad Laboratories, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Becton, Dickinson and Company (BD)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global point-of-care molecular diagnostics market size is expected to increase USD 12.61 billion by 2034 from USD 8.65 billion in 2024.

The global point-of-care molecular diagnostics market will register growth rate of 3.87% between 2025 and 2034.

The major players operating in the point-of-care molecular diagnostics market are Abbott Laboratories, Inc., Roche Diagnostics, bioMérieux SA, Danaher Corporation (Beckman Coulter), Cepheid (a subsidiary of Danaher Corporation), QIAGEN N.V., Thermo Fisher Scientific, Inc., Hologic, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company (BD), GenMark Diagnostics, Inc., Meridian Bioscience, Inc., Mesa Biotech, Inc., Biocartis Group NV, QuantuMDx Group Limited, and Others.

The driving factors of the point-of-care molecular diagnostics market are the demand for rapid diagnostic results and the miniaturization of diagnostic devices significantly surges market demand.

North America region will lead the global point-of-care molecular diagnostics market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client